SWS Medical Unveils Next-Generation Kidney Solutions at ERA 2026

SWS Medical is set to mark its debut at the ERA Congress 2026 from June 3 to June 6 in Glasgow, welcoming nephrologists, industry leaders, and partners at Booth D-350. This landmark event will showcase the company’s state-of-the-art blood purification solutions. With a strong emphasis on innovation, SWS Medical aims to expand its international presence in the fields of dialysis and intensive care medicine.

At this year's congress, the company will present its next-generation dialysis and CRRT (Continuous Renal Replacement Therapy) platforms, which are designed with intelligent automation and connected care in mind. These platforms promise to enhance workflow efficiency and streamline integrated therapy processes. Among the highlights are the SWS-4000 and SWS-6000 series, remarkably regarded in China’s dialysis market, collectively capturing an estimated 20 percent of the country's dialysis machine market in 2025.

The flagship model, the SWS-6000, is notable for being the only dialysis device in China that offers certified monitoring of essential treatment parameters. Complementing this, the SWS-4000 model features an online HDF (Hemodiafiltration) system that manufactures sterile liquids, thus facilitating a safer patient treatment process through intelligent monitoring.

Another focal point is the CE-certified SWS-5000, which has been recognized as China’s top CRRT device for three consecutive years. This award-winning all-in-one platform is built for integrated blood purification across multiple organ treatments, including kidney, liver, heart, lung, and pancreas support.

Additionally, SWS Medical’s product lineup includes advanced dialyzers manufactured with proprietary pre-vacuum steam pressure sterilization techniques and 100% BPA-free materials. These components ensure high solute clearance and reliable ultrafiltration performance, providing quality care for patients requiring dialysis. The portfolio also comprises dialysis fluid filters and hemoperfusion cartridges, further enhancing the treatment landscape.

To propel its strategy of connected care, the Integrated Management Platform from SWS Medical effectively links dialysis centers, physicians, and patients, leveraging tools like the Data Hub, Patient Card, and Hemodialysis Management System to convert data into safer and smarter healthcare practices.

Headquartered in Chongqing, China, SWS Medical is a publicly traded company (STAR Market, SSE 688410) that specializes in blood purification solutions for dialysis and intensive care. As a leader in advancing China's blood purification sector, SWS Medical holds the chairmanship of the China Blood Purification Industry Technology Innovation Strategic Alliance, actively contributing to the development of national and industry-wide standards.

With a commitment to global operations, the company ensures its products meet rigorous international quality and regulatory standards, including CE certification and conformity with ISO 13485:2016. This dedication positions SWS Medical as a frontrunner in delivering innovative healthcare solutions on a global scale.

As SWS Medical embarks on this exciting new chapter at ERA 2026, it sets forth a path of innovation and quality in the field of kidney health, reinforcing its mission to lead in advancing medical technologies and improving patient outcomes worldwide.

For more information, visit swsdialysis.com